Abstract
The already well-heeled Broad Institute in Cambridge, Massachusetts, this week announced a $100 million gift from a wealthy direct marketer to conduct research on severe mental illnesses such as bipolar disorder and schizophrenia. The funding from the Stanley Medical Research Institute will allow the Broad—a joint venture between the Massachusetts Institute of Technology and Harvard University—to create an interdisciplinary center that will draw on the universities' expertise in neuroscience and genomics. That center, located within the Broad Institute, will be led by Edward Scolnick, a former National Institutes of Health researcher and president of Merck Research Laboratories. The money from the Stanley Institute, founded by the family of Theodore and Vada Stanley, will help Broad researchers apply “the most advanced genomic tools” to the biology of mental illness, says Harvard Provost Steven Hyman.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
